C-Reactive Protein Rapid Test Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay (CLIA), Others); End User (Hospitals, Diagnostic Laboratories, Others), and Geography
Report Code: TIPRE00021650
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
CRP test is an important point-of-care assay to help discriminate serious illness such as pneumonia from often self-limiting illness like acute bronchitis and other respiratory tract infections. The rapid test gives result in 3-4 minutes.
The C-reactive protein rapid test market is driving due to the increasing prevalence of arthritis and osteoporosis, rising geriatric population, and technological advancements. However, high cost associated with the surgery and stringent regulations is expected to hamper the growth of the global C-reactive protein rapid test market.
The "C-Reactive Protein Rapid Test Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of C-reactive protein rapid test market with detailed market segmentation by type and end user. The C-reactive protein rapid test market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in C-reactive protein rapid test market and offers key trends and opportunities in the market.
The C-reactive protein rapid test market is segmented on the basis of type and end user. Based on type, the market is segmented as immunoturbidimetric assay, ELISA, chemiluminescence immunoassay, and others. On the basis of end user, the market is categorized as hospitals, diagnostic laboratories, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the C-reactive protein rapid test market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The C-reactive protein rapid test market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting C-reactive protein rapid test market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the C-reactive protein rapid test market in these regions.
Get more information on this report :
The report covers key developments in the C-reactive protein rapid test market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from C-reactive protein rapid test market are anticipated to have lucrative growth opportunities in the future with the rising demand for C-reactive protein rapid test in the global market. Below mentioned is the list of few companies engaged in the C-reactive protein rapid test market.
The report also includes the profiles of key players in C-reactive protein rapid test market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Thermo Fisher Scientific, Inc.
F Hoffmann-La Roche Ltd.
Ortho Clinical Diagnostics
Laboratory Corporation of America Holdings
Merck and Co., Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. HORIBA Ltd.
2. Thermo Fisher Scientific, Inc.
3. F Hoffmann-La Roche Ltd.
4. Quest Diagnostics
6. Siemens Healthineers
8. Ortho Clinical Diagnostics
9. Laboratory Corporation of America Holdings
10. Merck and Co., Inc.
11. BIOTECHNE (R AND D SYSTEMS)
13. RANDOX LABORATORIES LTD
14. LIFESPAN BIOSCIENCES, INC
15. ABAXIS, INC.